Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00401128 · ClinicalTrials.gov registry record · Phase 2

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

A Phase 2 study of Kidney Cancer, sponsored by The Cleveland Clinic.

Completed
Registry status
Phase 2
Development phase
9
Enrollment target
1
Study location

NCT00401128 is a Phase 2 study of Kidney Cancer that has completed, run by The Cleveland Clinic. The registered enrollment target is 9 participants, below the 880-participant average among 60 other Kidney Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00401128, a Phase 2 study of Kidney Cancer, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
Phase 2
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying the side effects and how well giving gemcitabine together with irinotecan works in treating patients with metastatic kidney cancer.

Conditions Studied

Kidney Cancer

Interventions

  • DRUG irinotecan hydrochloride
  • DRUG gemcitabine hydrochloride

Study Locations (1)

Ohio

  • Case Comprehensive Cancer Center - Cleveland

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2004-05
Est. Completion 2007-02
Phase Phase 2

Sponsor

The Cleveland Clinic

688 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00401128

The ClinicalTrials.gov registry entry for NCT00401128 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 880-participant average among 60 other Kidney Cancer trials with a reported enrollment target (99% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Cancer appearing as the primary indexed condition, and to 2 interventions - of which irinotecan hydrochloride is the first listed.

NCT00401128 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00401128 about?

NCT00401128 is a clinical study titled "Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer". RATIONALE: Drugs used in chemotherapy, such as gemcitabine and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II ...

What is the current status of trial NCT00401128?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2004-05. Estimated completion is 2007-02.

What conditions does trial NCT00401128 study?

This clinical trial studies the following conditions: Kidney Cancer.

What interventions are being tested in trial NCT00401128?

The interventions under investigation include: irinotecan hydrochloride (DRUG), gemcitabine hydrochloride (DRUG).

Who is sponsoring clinical trial NCT00401128?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00401128 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Cancer

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.